source
- Acting FDA chief vows to shield rare-disease discussions from political influenceActing FDA Commissioner Kyle Diamantas met with executives from fifteen rare‑disease nonprofit groups and senior agency staff. During the gathering he emphasized a new approach that differs from th…
- Otsuka showcases kidney drug data; Pfizer cuts an AI dealVoyxact helped preserve kidney function, but left an opening for competing IgAN drugs from Vera and Vertex. Elsewhere, Takeda’s alliance with Innovent paid early dividends and Axsome warded off gen…